News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
ADAMS JULIAN
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/07/2023 |
3
| ADAMS JULIAN (Director) has filed a Form 3 on Elicio Therapeutics, Inc. |
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/22/2022 |
4
| ADAMS JULIAN (Director) has filed a Form 4 on Gamida Cell Ltd.|
Txns:
| Granted 2,000 shares
@ $0
Granted 9,500 options to buy
@ $1.79, valued at
$17k
|
|
| 08/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2022 |
3
| ADAMS JULIAN (CEO) has filed a Form 3 on Gamida Cell Ltd. |
| 06/26/2018 |
3
| ADAMS JULIAN (Director) has filed a Form 3 on Neon Therapeutics, Inc. |
| 01/30/2017 |
4
| ADAMS JULIAN (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC. |
| 11/02/2016 |
4
| ADAMS JULIAN (President of R&D) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 59,150 shares
@ $0 |
|
| 07/26/2016 |
4
| ADAMS JULIAN (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC. |
| 07/26/2016 |
3
| ADAMS JULIAN (Director) has filed a Form 3 on PIERIS PHARMACEUTICALS, INC. |
| 01/08/2016 |
4
| ADAMS JULIAN (President of R&D) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 80,000 options to buy
@ $6.71, valued at
$536.8k
|
|
| 01/16/2015 |
4
| ADAMS JULIAN (President of R&D) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 125,000 options to buy
@ $15.74, valued at
$2M
|
|
| 01/14/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/08/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/09/2012 |
4
| ADAMS JULIAN (President of R&D) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 126,850 options to buy
@ $7.93, valued at
$1M
|
|
| 01/07/2011 |
4
| ADAMS JULIAN (President of R&D) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 106,210 options to buy
@ $5.94, valued at
$630.9k
|
|
| 01/07/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/07/2009 |
4
| ADAMS JULIAN (President of R&D and CSO) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC. |
| 12/08/2008 |
4
| ADAMS JULIAN (Chief Scientific Officer) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC. |
|
|